Strong Demand for Triple-TOF 5600 Drives AB Sciex's Q1 Revenue Growth | GenomeWeb

Danaher reported this week that core revenues at AB Sciex grew at high single-digit rates in the first quarter, driven by strong sales of its Triple-TOF 5600 mass spectrometer.

The "Triple-TOF 5600 led the way," Danaher CEO Larry Culp said during a conference call following the release of the earnings results, noting also that AB Sciex saw "robust demand" from the academic, proteomics, and applied markets.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.